Impact of breast cancer history on decision-making for ovarian cancer risk-reducing surgery in the TUBA-WISP-II study
American Journal of Obstetrics and Gynecology · 2025
DOI: 10.1016/j.ajog.2025.06.024 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Obstetrics and Gynecology, 2025. Verfasst von Tamar A Gootzen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: tamar.gootzen@radboudumc.n…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Salpingo-oophorectomy, Breast Neoplasms, Salpingectomy. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Any Mountain, Kurt Weill Foundation for Music, Dutch Cancer Society.
Abstract (Originalsprache)
BACKGROUND: Female BRCA1/2 pathogenic variant carriers have an increased risk of breast and ovarian cancer. In the TUBA-WISP II study, women chose between standard risk-reducing salpingo-oophorectomy and risk-reducing salpingectomy with delayed oophorectomy to prevent ovarian cancer. At inclusion, a substantial proportion of the enrolled women had a history of breast cancer, which could affect decision-making. OBJECTIVE: This study aimed to describe decision-making regarding the type and timing of risk-reducing surgery between women with and without a history of breast cancer. STUDY DESIGN: Premenopausal BRCA1/2 pathogenic variant carriers completed Web-based questionnaires on their personal histories and preferred risk-reducing strategy. Differences in the type and timing of the first risk-reducing surgery between women with and without a history of breast cancer were assessed. A multivariate analysis was performed to examine personal, environmental, and breast cancer-related characteristics associated with the choice of risk-reducing salpingo-oophorectomy among women with a history of breast cancer. RESULTS: This study included 1676 women, among whom 222 (13.2%) had a history of breast cancer. Of note, 77.0% of women with a history of breast cancer chose risk-reducing salpingectomy with delayed oophorectomy compared with 78.0% of women without a history of breast cancer (P=.73). Individuals with breast cancer before their BRCA1/2 diagnosis had their first surgery at a median of 2 years later than those who were diagnosed simultaneously or had their BRCA1/2 diagnosis first. Women diagnosed with breast cancer within the guideline age range for completing risk-reducing salpingo-oophorectomy (35-40 years for BRCA1 and 40-45 years for BRCA2) more often chose risk-reducing salpingo-oophorectomy than those before the guideline age range (odds ratio, 6.2 [95% confidence interval, 1.9-19.9]). CONCLUSION: A history of breast cancer was not associated with a preference for a specific risk-reducing strategy. Women diagnosed with breast cancer within the guideline age range more often chose risk-reducing salpingo-oophorectomy than those diagnosed with breast cancer before the guideline age range.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology and Obstetrics, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: tamar.gootzen@radboudumc.nl.
- Department of Gynecology and Obstetrics, Radboud University Medical Center, Nijmegen, The Netherlands.
- Institute for Quantitative Health Science Department, Radboud University Medical Center, Nijmegen, The Netherlands.
- Department of Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
- Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
- Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX.
Förderung
- Any Mountain
- Kurt Weill Foundation for Music
- Dutch Cancer Society
Zitieren
APA
Gootzen, T. A., Steenbeek, M. P., van Gelder, M. M. H. J., van Bommel, M. H. D., Timmer-Bonte, A. J. N. H., Kets, C. M., Nitecki-Wilke, R., Swisher, E. M., Norquist, B. M., Lu, K. H., Hermens, R. P. M. G., de Hullu, J. A., & TUBA-WISP II Consortium (2025). Impact of breast cancer history on decision-making for ovarian cancer risk-reducing surgery in the TUBA-WISP-II study. American Journal of Obstetrics and Gynecology. https://doi.org/10.1016/j.ajog.2025.06.024
Vancouver
Gootzen TA, Steenbeek MP, van Gelder MMHJ, van Bommel MHD, Timmer-Bonte AJNH, Kets CM, et al. Impact of breast cancer history on decision-making for ovarian cancer risk-reducing surgery in the TUBA-WISP-II study. American Journal of Obstetrics and Gynecology. 2025. doi:10.1016/j.ajog.2025.06.024
BibTeX
@article{Gootzen2025,
author = {Gootzen, Tamar A and Steenbeek, Miranda P and van Gelder, Marleen M H J and van Bommel, Majke H D and Timmer-Bonte, Anja J N H and Kets, C Marleen and Nitecki-Wilke, Roni and Swisher, Elizabeth M and Norquist, Barbara M and Lu, Karen H and Hermens, Rosella P M G and de Hullu, Joanne A and TUBA-WISP II Consortium, TUBA-WISP II Consortium},
title = {Impact of breast cancer history on decision-making for ovarian cancer risk-reducing surgery in the TUBA-WISP-II study},
journal = {American Journal of Obstetrics and Gynecology},
year = {2025},
doi = {10.1016/j.ajog.2025.06.024}
}
EUVIMED